@Lfc786 did ponder thusly: "why would the big boys care about this Co when they already have the market by its collar...?"
I think CEO Wayne Paterson has it correctly when he says clinical data always wins out. If either of the 2 major SAVR/TAVR players determine the data from Anteris is as good as promoted, then they'll either have to trump it with something of their own pretty fast, acquire it, or lose the race to whoever picks it up.
But you raise an interesting question:
" only one I can see interested is a smaller player who would want to upset the applecart ..."
Is there a 3rd player scenario? A global company in the heart-device space with the stature to enter what at present is a 2-horse race?
meanwhile, as for AVR/AVRO market price: how can this last? Before I fall out of bed and woke up?
Regards,
P
"Toot Toot", page-253
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |